Methods of Diagnosing or Treating Prostate Cancer Using the ERG Gene, Alone or in Combination with Other over or Under Expressed Genes in Prostate Cancer

作者: Gyorgy Petrovics , Shiv Srivastava

DOI:

关键词:

摘要: The present invention relates to oncogenes or tumor suppressor genes, as well other involved in prostate cancer and their expression products, derivatives analogs thereof. Provided are therapeutic compositions methods of detecting treating cancer, including related cancers. Also provided diagnosing and/or prognosing by determining the level at least one cancer-cell-specific gene, including, for example, ERG gene LTF alone, combination with AMACR DD3 gene.

参考文章(94)
Mark A Rubin, Ming Zhou, Saravana M Dhanasekaran, Sooryanarayana Varambally, Terrence R Barrette, Martin G Sanda, Kenneth J Pienta, Debashis Ghosh, Arul M Chinnaiyan, α-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer JAMA. ,vol. 287, pp. 1662- 1670 ,(2002) , 10.1001/JAMA.287.13.1662
Saravana M. Dhanasekaran, Terrence R. Barrette, Debashis Ghosh, Rajal Shah, Sooryanarayana Varambally, Kotoku Kurachi, Kenneth J. Pienta, Mark A. Rubin, Arul M. Chinnaiyan, Delineation of prognostic biomarkers in prostate cancer. Nature. ,vol. 412, pp. 822- 826 ,(2001) , 10.1038/35090585
Virginie Vlaeminck-Guillem, Jean-Marc Vanacker, Alexis Verger, Nathalie Tomavo, Dominique Stehelin, Vincent Laudet, Martine Duterque-Coquillaud, Mutual repression of transcriptional activation between the ETS-related factor ERG and estrogen receptor Oncogene. ,vol. 22, pp. 8072- 8084 ,(2003) , 10.1038/SJ.ONC.1207094
Sudhir Srivastava, Donald Earl Henson, Adi F Gazdar, None, Molecular Pathology of Early Cancer Melanoma Research. ,vol. 9, pp. 419- ,(1999) , 10.1097/00008390-199908000-00013
Shunyou Wang, Jing Gao, Qunying Lei, Nora Rozengurt, Colin Pritchard, Jing Jiao, George V. Thomas, Gang Li, Pradip Roy-Burman, Peter S. Nelson, Xin Liu, Hong Wu, Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Cancer Cell. ,vol. 4, pp. 209- 221 ,(2003) , 10.1016/S1535-6108(03)00215-0
Tsuneyuki Oikawa, ETS transcription factors: possible targets for cancer therapy. Cancer Science. ,vol. 95, pp. 626- 633 ,(2004) , 10.1111/J.1349-7006.2004.TB03320.X
K. Shimizu, H. Ichikawa, A. Tojo, Y. Kaneko, N. Maseki, Y. Hayashi, M. Ohira, S. Asano, M. Ohki, An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 10280- 10284 ,(1993) , 10.1073/PNAS.90.21.10280
Enrique de Alava, Javier Pardo, Ewing tumor: tumor biology and clinical applications. International Journal of Surgical Pathology. ,vol. 9, pp. 7- 17 ,(2001) , 10.1177/106689690100900104
Mark Frydenberg, Prostate Cancer: Diagnosis and Surgical Treatment. Anz Journal of Surgery. ,vol. 74, pp. 187- 187 ,(2004) , 10.1046/J.1445-2197.2003.02925.X
Stephen D. Mikolajczyk, Yong Song, James R. Wong, Robert S. Matson, Harry G. Rittenhouse, Are multiple markers the future of prostate cancer diagnostics? Clinical Biochemistry. ,vol. 37, pp. 519- 528 ,(2004) , 10.1016/J.CLINBIOCHEM.2004.05.016